endometrial hyperplasia/edema

Lyen an sove nan clipboard la

AtikEsè klinikPatant

Chwazi kalite sòt

12 rezilta yo

Apoptotic signaling pathways in uteri of rats with endometrial hyperplasia induced by ovariectomy combined with estrogen.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To explore a new reliable method inducing an animal model similar to the morphology and apoptotic signaling pathways in endometrial hyperplasia patients. METHODS After the rats were ovariectomized, estradiol benzoate (60 µg/100 g) was intramuscularly injected on alternate days for 4

The anorectic agent, lorcaserin, disturbs estrous cyclicity and produces endometrial hyperplasia without affecting ovarian population in female rats.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE The present study aims to investigate the effect of the new anorectic agent, lorcaserin, on estrous cyclicity, reproductive hormones and folliculogenesis in female mature rats. METHODS Rats were divided into four groups; Group i: control group. Group ii-iv: rats treated with lorcaserin (5,

Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

During menopause vasomotor symptoms are one of the main complaints about which women seek medical advice. For symptom control, several therapies have been used, among which hormone therapy has produced good results. One of these is estrogen monotherapy, which unfortunately may induce endometrial

A 30-day preclinical safety evaluation study of recombinant human follicle-stimulating hormone in female rhesus monkeys.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The objective of this study was to identify potential target organs for toxicity of recombinant human follicle stimulating hormone (r-hFSH) in female rhesus monkeys and to establish a no observed adverse effect level (NOAEL). In all, 24 female rhesus monkeys (Chinese origin, weighing 3.4-5.2 kg,

Ultrasonographic and laparoscopic evaluation of the reproductive tract in older captive female cheetahs (Acinonyx jubatus).

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The study uniquely described the clinical value of transabdominal ultrasonography for monitoring features characterizing the estrous cycle in female cheetahs (Acinonyx jubatus). The reproductive tracts of 21 female, nulliparous, and relatively aged (median: 11 and interquartile range: 9.25-14 years)

Hormonal pathology of the endometrium.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The endometrial tissue is a sensitive target for steroid sex hormones and is able to modify its structural characteristics with promptness and versatility. This article discusses briefly endogenous hormonal effects (cyclic changes, luteal phase defect, unopposed estrogen effect) and describes the

Concomitant Presence of Ovarian Tumors (Teratoma and Granulosa Cell Tumor), and Pyometra in an English Bulldog Female Dog: A Case Report.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Background: The diagnosis of ovarian tumors in dogs is usually complicated because the clinical signs can be very discrete and can be easily confused with other diseases. There are few reports of ovarian tumors with different cellular characteristics in the same dog. Our objective was to

[Pathology associated with uterine leiomyoma: review of 600 cases].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The authors analyzed 600 patients with uterine leiomyoma examined at the Escola Paulista de Medicina and submitted to surgical treatment between 1976 and 1987. The uteri were carefully studied and leiomyomas were confirmed. Other diseases were also found in 71.17% of the cases. Uteri from

Compliance considerations with estrogen replacement: withdrawal bleeding and other factors.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Withdrawal bleeding and other side effects such as edema, bloating, premenstrual irritability, lower abdominal cramps, dysmenorrhea, and breast tenderness limit compliance with hormonal replacement therapy. Although many of these troublesome side effects can be managed by adjusting the dose or

Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND To decrease exposure to progestin during hormone replacement therapy (HRT), a novel oral regimen consisting of constant 17beta-estradiol (E2) daily plus intermittent norgestimate (NGM) has been developed. METHODS A multicenter study compared the safety and efficacy of E2 1 mg daily plus

Computational molecular docking assessment of hormone receptor adjuvant drugs: Breast cancer as an example.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

For the maintenance therapy of breast cancer, drugs which act as antagonists/partial agonists of hormone receptors against the breast tissue are used in the conventional clinical practices. However, during the course of treatment the patients may encounter systems related complications. Drugs like

Spotlight on estradiol and norgestimate as hormone replacement therapy in postmenopausal women.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The focus of this review is hormone replacement therapy (HRT) with continuous administration of micronized, oral 17beta-estradiol 1 mg/day (herein referred to as continuous estradiol) plus micronized, oral norgestimate 90 microg/day administered for 3 days then withdrawn for 3 days in a 6-day

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye